Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2025-10-08 00:00:00 ET · period of report 2025-10-06 · accession 0000874015-25-000252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-08 | 2025-10-06 | IONS | Monia Brett P | CEO, Dir | S - Sale | $69.26 | -437 | 179.6K | -0.2% | -$30.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-06 | S | D | 437 | $69.26 | 179,572 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024. |